 |
Depósito mínimo $50 Promoción exclusiva |
Nuestra puntuación |
Comisión 0% |
Are you looking to buy OncoCyte stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy AMEX:OCX! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about OncoCyte stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
OncoCyte Corporation engages in the development and commercialization of proprietary laboratory-developed tests for the detection of cancer. The company offers DetermaRx, a molecular tests for early stage adenocarcinoma of the lung; and DetermaIO, a novel gene expression-based tests. It also develops DetermaDx, a non-invasive blood-based tests used to detect lung cancer. OncoCyte Corporation has a strategic collaboration with Guardian Research Network, Inc. to create a solution for pharma clients from patient recruitment to regulatory approvals. The company was founded in 2009 and is headquartered in Irvine, California.
Volumen medio
1.78 million shs
TAPA DEL MERCADO
$402.16 million
Bolsa
NYSEAMERICAN
¡Compre esta acción!
|
NOMBRE
|
TICKER
|
INDUSTRIA
|
SECTOR
|
VOLUMEN
|
COMPRE ESTA ACCIÓN AHORA
|
|---|---|---|---|---|---|
|
AMEX:OCX
|
Sustancias de diagnóstico
|
Médico
|
101,349 shs
|
Below is a quick guide on how to buy AMEX:OCX stocks safe, fast and around the world in less than five minutes.
Paso 1: Abrir una cuenta en eToro – eToro is the best broker to buy OncoCyte shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Paso 2: Suba su identificación - Según las regulaciones de KYC, eToro le pedirá que suba una copia de su pasaporte o licencia de conducir.
Paso 3: Depositar los fondos - Deposite algo de dinero en su recién creada cuenta de eToro. Puede elegir entre transferencia bancaria, monedero electrónico o tarjeta de débito/crédito o Paypal.
Paso 4: Buy OncoCyte – Search for “”AMEX:OCX”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought OncoCyte stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
7 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for OncoCyte in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” OncoCyte stock.
Wall Street analysts have given OncoCyte a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but OncoCyte wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
2 |  | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
3 |  | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing AMEX:OCX stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy OncoCyte stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy OncoCyte stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Debido a que eToro es una plataforma regulada, tendrá que completar el proceso KYC, esto es una práctica estándar y sólo toma un par de minutos. Tendrá que proporcionar un documento de identidad con fotografía (pasaporte, permiso de conducir) y un comprobante de domicilio (factura de servicios públicos, extracto bancario).
Una vez que se haya registrado y verificado su cuenta, deberá depositar fondos. eToro acepta tarjetas de crédito/débito, transferencias bancarias y también monederos electrónicos. Así que, sea cual sea su preferencia, habrá algo para usted.
Now that you’ve funded your eToro account, just type “AMEX:OCX stocks" en la barra de búsqueda de la parte superior de la pantalla y pulse "comercio".
All that’s left is to buy some AMEX:OCX stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, AMEX:OCX is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy OncoCyte stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
OncoCyte is scheduled to release its next quarterly earnings announcement on Wednesday, March 24th 2021.
View our earnings forecast for OncoCyte.
OncoCyte Co. (NYSEAMERICAN:OCX) posted its quarterly earnings data on Thursday, November, 12th. The biotechnology company reported ($0.10) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.09) by $0.01. The biotechnology company had revenue of $0.56 million for the quarter, compared to the consensus estimate of $0.62 million.
View OncoCyte’s earnings history.
OncoCyte’s stock was trading at $2.14 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, OCX shares have increased by 176.6% and is now trading at $5.92.
7 brokerages have issued 1-year target prices for OncoCyte’s stock. Their forecasts range from $4.00 to $7.75. On average, they expect OncoCyte’s stock price to reach $5.11 in the next year. This suggests that the stock has a possible downside of 13.7%.
View analysts’ price targets for OncoCyte or view top-rated stocks among Wall Street analysts.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying AMEX:OCX stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Más de 95% de los fondos de los clientes se mantienen fuera de línea, en almacenamiento en frío, lo que es crucial para cualquier corredor que gestione sus activos. Independientemente de lo segura que sea una plataforma, le recomendamos que utilice el sistema 2FA para añadir una capa adicional de seguridad a su cuenta.
eToro ofrece a los usuarios una serie de características para empezar a invertir lo antes posible. Tienen una característica relativamente única llamada copy trading, que le permite obtener un ingreso pasivo al imitar a operadores experimentados, esto le permite comenzar a obtener ganancias rápidamente, y le da una mejor comprensión de las estrategias utilizadas por los profesionales. Además, eToro permite a los usuarios invertir en carteras gestionadas, siendo una cartera gestionada una variedad de activos similares agrupados, lo que le permite diversificar su cuenta, reduciendo cualquier riesgo potencial. Para aquellos con experiencia previa en operaciones, puede invertir en mercados fuera de las acciones, ya que eToro permite a los usuarios operar con ETFs, materias primas, cripto e índices. Si ya invierte fuera del espacio bursátil, esto puede ser muy útil, ya que le permite gestionar todas sus inversiones en un solo lugar.
OncoCyte saw a decrease in short interest in the month of December. As of December 31st, there was short interest totaling 2,220,000 shares, a decrease of 14.3% from the December 15th total of 2,590,000 shares. Based on an average daily volume of 2,090,000 shares, the days-to-cover ratio is currently 1.1 days.
View OncoCyte’s Short Interest.
OncoCyte’s management team includes the following people:
Mr. Ronald A. Andrews Jr., CEO, Pres & Director (Age 61, Pay $312.5k)
Mr. Mitchell S. Levine, Chief Financial Officer
Mr. William Annett, Advisor (Age 67, Pay $673.33k)
Ms. Padma Sundar, Sr. VP of Commercial
Dr. Douglas T. Ross M.D., Ph.D., Chief Medical Officer
Dr. Michael D. West, Scientific Advisor, Co-CEO of Biotime,Inc. & Pres of Biotime,Inc. (Age 68)
Ms. Sara Riordan, Director of Medical Education
Los CFD son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento. 68% de las cuentas de inversores minoristas pierden dinero al operar con CFDs con este proveedor. Debe considerar si entiende cómo funcionan los CFD y si puede permitirse asumir el alto riesgo de perder su dinero.
Some companies that are related to OncoCyte include Riot Blockchain (RIOT), Lantheus (LNTH), Meridian Bioscience (VIVO), Celldex Therapeutics (CLDX), Aspira Women’s Health (AWH), Oxford Immunotec Global (OXFD), Quotient (QTNT), VolitionRx (VNRX), Nymox Pharmaceutical (NYMX), Trinity Biotech (TRIB), Biomerica (BMRA), ImmuCell (ICCC), Navidea Biopharmaceuticals (NAVB), Achieve Life Sciences (ACHV) and StageZero Life Sciences (GNWSF).
View all of OCX’s competitors.
Based on aggregate information from Reportlab, some companies that other OncoCyte investors own include Alibaba Group (BABA), BioTime (BTX), Fulcrum Therapeutics (FULC), Alnylam Pharmaceuticals (ALNY), VIVUS (VVUS), Anavex Life Sciences (AVXL), CymaBay Therapeutics (CBAY), AcelRx Pharmaceuticals (ACRX), Agile Therapeutics (AGRX) and Aldeyra Therapeutics (ALDX).
OncoCyte trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol “OCX.”
OncoCyte’s stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (5.21%), Penbrook Management LLC (0.63%), GSA Capital Partners LLP (0.25%), Nisa Investment Advisors LLC (0.18%) and Caliber Wealth Management LLC (0.05%). Company insiders that own OncoCyte stock include Albert P Parker, Alfred D Kingsley, Andrew Arno, Biotime Inc, Broadwood Partners, LP, Mitchell S Levine, Ronald Asbury Andrews and Thomas Alex Vetter.
View institutional ownership trends for OncoCyte.
1 | | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
OCX stock was sold by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP.
View insider buying and selling activity for OncoCyte or view top insider-selling stocks.
OCX stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Penbrook Management LLC, Nisa Investment Advisors LLC, and Caliber Wealth Management LLC. Company insiders that have bought OncoCyte stock in the last two years include Albert P Parker, Andrew Arno, Broadwood Partners, LP, Mitchell S Levine, Ronald Asbury Andrews, and Thomas Alex Vetter.
View insider buying and selling activity for OncoCyte or or view top insider-buying stocks.
Shares of OCX can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisión de Interactive Brokers, Revisión de eToro, Revisión de DEGiro, Revisión de AvaTrade, Revisión de IG Markets, Revisión de los mercados IC, Revisión de CMC Markets, Revisión de Admiral Markets y muchos más. Lea una de las reseñas para saber todo sobre el corredor y comience a comprar acciones ahora.
One share of OCX stock can currently be purchased for approximately $5.92.
OncoCyte has a market capitalization of $398.13 million. The biotechnology company earns $-22,430,000.00 in net income (profit) each year or ($0.44) on an earnings per share basis.
OncoCyte employs 33 workers across the globe.
En Reportlab.org queremos asegurarnos de que tenga toda la información más relevante sobre compra de acciones. Le ofrecemos las mejores guías sobre el mercado de valores con reseñas personales, información de fondo, reseñas de las plataformas, instrucciones y mucho más. ¿Quiere obtener otra información? Entonces consulte la Acciones OTC, Acciones del NASDAQ, Acciones de la Bolsa de Valores de Nueva York, Acciones LON, Acciones de la FRA, Acciones ETR, Reservas de la EPA, Acciones del TSX o Acciones Amex. Buscando información más detallada como 5g de existencias, acciones de biotecnología, acciones de oro y otra información de nuestro laboratorio de informes.
How can you buy OncoCyte stock on the internet?
You can easily buy OncoCyte stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Otra opción es utilizar un corredor regulado como Mercados IC o Corredores de bolsa interactivos. You can an account with these brokers and start buying or trading AMEX:OCX stocks in a safe and complete environment to trade in.
Where to buy OncoCyte stock?
You will first want to find a licensed broker that supports AMEX:OCX stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading AMEX:OCX stocks in a safe and complete environment.
Is AMEX:OCX stock a good investment?
As with any other asset, there is an element of risk associated with buying AMEX:OCX stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is OncoCyte stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with AMEX:OCX is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in OncoCyte stock.
How do you trade OncoCyte stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for OncoCyte stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on AMEX:OCX stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell OncoCyte stock?
To sell your AMEX:OCX stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best OncoCyte stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading AMEX:OCX stock.
Stephen sabe mucho sobre productos financieros y, en particular, tiene una gran pasión por los mercados de valores y sus participantes. Esperamos que la información proporcionada le sirva de ayuda. ¿Hay algo que no está claro? Deje sus preguntas o comentarios al final de la página.
| Nuestra puntuación ★★★★★ | |
| Nuestra puntuación ★★★★★ | |
| Nuestra puntuación ★★★★★ |
Boletín de noticias
Noticias recientes
| |
Nuestra puntuación |
Comisión 0% |
Datos de acciones y criptografía en tiempo real
Notificaciones, consejos y noticias
Las mejores guías sobre acciones y criptografía
Reseñas sobre el corredor y la bolsa en línea
Reportlab Finanzas es una página web puramente informativa y en ningún caso implica un asesoramiento de inversión. Todas las inversiones conllevan riesgos y usted puede perder todas sus inversiones. No invierta dinero que no pueda permitirse perder.
Reportlab Finanzas
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos los derechos reservados.
